Cited by 1,179RNA Research and SplicingCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer

Open access
David, Charles J., Chen, Mo, Assanah, Marcela, Canoll, Peter, Manley, James L.·2010·Nature

Abstract

When oxygen is abundant, quiescent cells efficiently extract energy from glucose primarily by oxidative phosphorylation, whereas under the same conditions tumour cells consume glucose more avidly, converting it to lactate. This long-observed phenomenon is known as aerobic glycolysis, and is important for cell growth. Because aerobic glycolysis is only useful to growing cells, it is tightly regulated in a proliferation-linked manner. In mammals, this is partly achieved through control of pyruvate kinase isoform expression. The embryonic pyruvate kinase isoform, PKM2, is almost universally re-expressed in cancer, and promotes aerobic glycolysis, whereas the adult isoform, PKM1, promotes oxidative phosphorylation. These two isoforms result from mutually exclusive alternative splicing of the PKM pre-mRNA, reflecting inclusion of either exon 9 (PKM1) or exon 10 (PKM2). Here we show that three heterogeneous nuclear ribonucleoprotein (hnRNP) proteins, polypyrimidine tract binding protein (PTB, also known as hnRNPI), hnRNPA1 and hnRNPA2, bind repressively to sequences flanking exon 9, resulting in exon 10 inclusion. We also demonstrate that the oncogenic transcription factor c-Myc upregulates transcription of PTB, hnRNPA1 and hnRNPA2, ensuring a high PKM2/PKM1 ratio. Establishing a relevance to cancer, we show that human gliomas overexpress c-Myc, PTB, hnRNPA1 and hnRNPA2 in a manner that correlates with PKM2 expression. Our results thus define a pathway that regulates an alternative splicing event required for tumour cell proliferation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature08697

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PKM splicing or the PKM2/PKM1 ratio is controlled by expression levels of hnRNPI, hnRNPA1 and hnRNPA2, which bind repressively to sequences flanking exon 9, favoring exon 10 addition and generating more PKM2 in cancer cells.

    “PKM splicing or the PKM2/PKM1 ratio is known to be controlled by the expression levels of nuclear ribonucleoprotein (hnRNP) proteins, hnRNPI, hnRNPA1 and hnRNPA2, and in cancer cells, these proteins are expressed at high levels and bind repressively to the sequences flanking exon 9, favoring the exon 10 addition thus generating more PKM2”
  • MYC promotes a high PKM2/PKM1 ratio by upregulating heterogeneous nuclear ribonucleoproteins (hnRNP) that regulate PKM alternative splicing.

    “MYC also promotes a high PKM2/PKM1 ratio by upregulating heterogeneous nuclear ribonucleoproteins (hnRNP) that regulate PKM alternative splicing (David et al., 2010).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L.
Affiliations
Columbia University (US)
Corresponding author
Manley, James L.
Venue
Nature
Published
2009-12-13
Volume
463
Issue
7279
Pages
364-368
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2048255587
Cited by
1,179
References
31
Citations by year
2026: 39 · 2025: 59 · 2024: 94 · 2023: 87 · 2022: 79 · 2021: 87 · 2020: 91 · 2019: 79 · 2018: 70 · 2017: 67 · 2016: 74 · 2015: 83 · 2014: 63 · 2013: 72 · 2012: 61
FWCI
17.83
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
National Institute of General Medical Sciences (R01GM048259)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
pyruvate kinase, PKM2, PKM1, alternative splicing, c-Myc, hnRNP proteins, PTB, hnRNP A1, hnRNP A2, aerobic glycolysis, oxidative phosphorylation, cancer metabolism, tumor suppressor, tumor suppressor microRNA, tumor suppressor lncRNA
MeSH terms
Animals, Exons, Glycolysis, Humans, Neoplasms, Oxidative Phosphorylation, Protein Binding, Pyruvate Kinase, RNA, Messenger, Genes, myc, Proto-Oncogene Proteins c-myc, Alternative Splicing, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Polypyrimidine Tract-Binding Protein, NIH 3T3 Cells, Cell Line, Tumor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review